HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Safer Consumer Products Compliance Costs Will Vary Widely

This article was originally published in The Tan Sheet

Executive Summary

The state toxic substances authority says “a simple single-chemical alternatives analysis” could cost $2,000 to $3,000, a moderately complex analysis with existing data “would be in the tens of thousands of dollars” and one “of greater complexity requiring extensive testing” could run in the hundreds of thousands.

You may also be interested in...



Pending Calif. Consumer Products Reg Inconsistent, Unfair – Trade Groups

The Personal Care Products Council and the Consumer Healthcare Products Association fault the latest and likely last draft of California’s Safer Consumer Products regs for its lack of a weight-of-evidence approach to decision making and inadequate trade-secret protections, among other shortcomings.

ECHA Provides Cues For Self-Assessing REACH Deadline Preparedness

As the May 31 REACH deadline approaches, dossier registrants should know their roles within SIEF registrant groups and ensure that dossiers clearly identify and characterize substances, says the European Chemicals Agency. Over 3,000 substances are expected to have been registered by June.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel